RVPH
Reviva Pharmaceuticals Holdings, Inc.
Phase 3
AI-extracted
brilaroxazine
schizophrenia
T-minus 267 days
~ Mar 31, 2027
SEC 8-K
verified 14h ago
Countdown card →